/Companies

Qubigen

1 known investors

Find your way into Qubigen

Qubigen provides end-to-end AI drug design as a service, using a global federated AI system and computational workflows to generate and optimize novel drug candidates for specific protein targets. Its federated approach draws insights from clients' protected, sensitive data without moving or viewing it, serving pharmaceutical and drug discovery researchers.

Investors · 1

Frequently asked questions

What does Qubigen do?
Qubigen provides end-to-end AI drug design as a service, using a global federated AI system and computational workflows to generate and optimize novel drug candidates for specific protein targets. Its federated approach draws insights from clients' protected, sensitive data without moving or viewing it, serving pharmaceutical and drug discovery researchers.
Who are Qubigen's investors?
Qubigen's investors include 3Lines Venture Capital.